Dagmar Rosa-Bjorkeson
Geschäftsführer bei MESOBLAST LIMITED
Vermögen: - $ am 30.04.2024
Aktive Positionen von Dagmar Rosa-Bjorkeson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| XENCOR, INC. | Direktor/Vorstandsmitglied | 18.12.2019 | - |
| Independent Dir/Board Member | 18.12.2019 | - | |
| MESOBLAST LIMITED | Geschäftsführer | 24.07.2020 | - |
| Deirdres House | Direktor/Vorstandsmitglied | - | - |
New Jersey City University Foundation
 New Jersey City University Foundation Other Consumer ServicesConsumer Services The New Jersey City University Foundation operates colleges and educational universities. The private company is based in New Jersey. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Dagmar Rosa-Bjorkeson
Ehemalige bekannte Positionen von Dagmar Rosa-Bjorkeson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.04.2021 | 08.11.2023 |
| Independent Dir/Board Member | 01.04.2021 | 08.11.2023 | |
| MALLINCKRODT PLC | Corporate Officer/Principal | 01.04.2018 | 01.01.2020 |
Mallinckrodt Medical, Inc. (US)
 Mallinckrodt Medical, Inc. (US) Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Medical, Inc. is a pharmaceutical company based in St. Louis. The American company manufactures pharmaceutical products. | Corporate Officer/Principal | 01.05.2017 | 01.01.2020 |
| BAXALTA INC | Corporate Officer/Principal | 01.01.2014 | 01.01.2016 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01.01.1997 | 01.01.2014 |
| ░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ | - | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Dagmar Rosa-Bjorkeson
| The University of Texas at Austin | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
| Vereinigtes Königreich | 2 |
| Schweden | 2 |
Operativ
| Corporate Officer/Principal | 5 |
| Director/Board Member | 4 |
| Independent Dir/Board Member | 2 |
Sektoral
| Health Technology | 9 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| MALLINCKRODT PLC | Health Technology |
| XENCOR, INC. | Health Technology |
| MESOBLAST LIMITED | Health Technology |
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
| Hoechst Pharmaceuticals Ltd. | |
Novartis Sverige AB
 Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Novartis Sverige AB trades pharmaceutical products. It offers products for the treatment of ADHD, multiple sclerosis, urticaria, allergic asthma, psoriasis, chronic obstructive pulmonary disorder, migraine, blood diseases, eye disorder, and other diseases. The company is headquartered in Kista, Sweden. | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
| Deirdres House | |
New Jersey City University Foundation
New Jersey City University Foundation Other Consumer ServicesConsumer Services The New Jersey City University Foundation operates colleges and educational universities. The private company is based in New Jersey. | Consumer Services |
Mallinckrodt Medical, Inc. (US)
Mallinckrodt Medical, Inc. (US) Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Medical, Inc. is a pharmaceutical company based in St. Louis. The American company manufactures pharmaceutical products. | Health Technology |
- Börse
- Insiders
- Dagmar Rosa-Bjorkeson
- Erfahrung
